BDNF and head and neck squamous cell carcinoma: After stable transfection with shRNA constructs targeting BDNF (shRNA-BDNF) or a non-targeting sequence (shRNA-NT), CAF cells were co-injected at a 5:1 ratio with HNSCC cell lines in the orthotopic tongue model.